COVID-19 Publications - Week 17 2021 1448 Publications

Total Page:16

File Type:pdf, Size:1020Kb

COVID-19 Publications - Week 17 2021 1448 Publications Update April 26 - May 02, 2021, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 17 2021 1448 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial) The Covid-Plex trial is an investigator initiated, multicenter, parallel-group, open-label randomized clinical trial aiming to randomize patients with severe COVID-19 to standard care or standard care plus plasmapheresis and convalescent plasma. If you are interested to participate Please contact Wladimir Szpirt, Nicholas Carlson Anders, or Perner Bo Feldt-Rasmussen. Depts. Of Intensive Care Therapy and Nephrology, Copenhagen University Hospital Rigshospitalet, Denmark Covid-Plex trial Mainstream Media New York Times - Corona update India’s vaccinations decline as its virus outbreak reaches new highs. Europe signals it may not support Biden’s call to waive Covid vaccine patents. Millions of Johnson & Johnson doses sit unused across three continents. Australia confirms it will allow its citizens to return home from India starting May 15, Want a coronavirus vaccine? U.S. pharmacies say walk right in. Pregnant women in Britain will be offered Covid-19 vaccines. Pfizer-BioNTech Vaccine is Highly Effective Against Variants, Studies Find Millions Are Skipping Their Second Doses of Covid Vaccines How Hard Could It Be to Vaccinate the Whole World? Washington Post - Corona update Drug companies dig in for global patent fight amid flow of billions in vaccine revenue The pandemic has led to innovation. It’s a reason for optimism. 149.5 million vaccinated Germany lets the vaccinated have a bit more fun. Teens shut out from the jabs are not happy. Europe's vaccine campaign is accelerating. It expects to match the U.S. by July. We could see a winter comeback of covid-19 if we don’t get more Americans vaccinated now Guardian - Corona update Covid-19 unlikely to be ever eradicated, warns Prof Chris Whitty New concerns as Indian Covid variant clusters found across England Tui to offer £20 Covid tests for travellers to green list countries EU wants to mass produce three ‘course-changing’ Covid drugs from October IOC and Pfizer strike vaccine deal for Tokyo Olympics competitors Key Articles 1. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals (Basel) 2021; 14Yan ZP, Yang M, Lai CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923054 In this phase of the COVID, pandemic vaccination efforts have become the focus of attention. To date, 86 vaccines are under development. This review shares the most relevant information of 12 vaccines currently deployed or very close to being released for clinical use. Efficacy and safety data of these vaccines in various populations are presented in a concise and systematic overview to provide health care providers with relevant information. 2. Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database. Vaccines (Basel) 2021; 9Tobaiqy M, Elkout H, MacLure K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33923530 From March 11th, several European countries suspended the use of the Astra Zeneca Oxford vaccine. The European Medical Agency (EMA) and World Health Organization came out with reassuring reports, and most, but not all, countries re-started the use of the Astra Zeneca Oxford vaccine. This review shares data collected in the Eudora Vigilance registry from February 17th – March 12th. Of the 17 million individuals that received the vaccine, 54 571 reported adverse events. Thrombotic complications occurred in 28 individuals, of which three died from pulmonary embolisms and one from thrombosis. The observed fatal complications were classified as extremely rare events, and the EMA concluded that the benefits far outweighed the risks. 3. Diagnosis and Management of Cerebral Venous Sinus Thrombosis with Vaccine-Induced Thrombotic Thrombocytopenia. Stroke 2021; American Heart Association/American Stroke Association Stroke Council L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33914590 Cerebral venous sinus thrombosis (CVST) is an extremely thrombotic rare complication that was reported in six cases after use of the Jansen – Johnson & Johnsen (JJJ) vaccine. Thrombotic complications were also reported after the use of the Astra Zeneca Oxford vaccine. Both vaccines share the use of adenoviral vectors. The mRNA based Pfizer and Moderna vaccines did not report any cases of thrombocytopenia associated CVST in 187 million vaccinated individuals. After initial suspension of the JJJ vaccine, the FDA has authorized the continuation of this vaccine, but advised clinicians to be aware of this extremely rare complication and this review provides clinicians with helpful information on CVST diagnosis and management 4. E-Triage Systems for COVID-19 Outbreak: Review and Recommendations. Sensors (Basel) 2021; 21Alhaidari F, Almuhaideb A, Alsunaidi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920744 5. Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. J Clin Med 2021; 10Wu CC, Lee AJ, Su CH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33916281 6. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med 2021; 10Wolf ME, Luz B, Niehaus L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33918932 7. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. Antib Ther 2020; 3:115- 125Verma HK, Farran B, Bhaskar L. http://www.ncbi.nlm.nih.gov/pubmed/? term=33912791 8. Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience. Clin Infect Dis 2021; Tran VT, Riveros C, Clepier B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33912905 9. Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management. Int J Environ Res Public Health 2021; 18Sisó- Almirall A, Brito-Zerón P, Conangla Ferrín L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33923972 10. Cancer as a prospective sequela of long COVID-19. Bioessays 2021:e2000331Saini G, Aneja R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33914346 11. Neurological update: COVID-19. J. Neurol. 2021:1-9Ren AL, Digby RJ, Needham EJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33929617 12. COVID-19: Direct and Indirect Mechanisms of Statins. Int J Mol Sci 2021; 22Pawlos A, Niedzielski M, Gorzelak-Pabiś P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33920709 13. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci 2021; 17:1446-1460Park JW, Lagniton PNP, Liu Y, Xu RH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33907508 14. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep 2021; 8:871-879Hernández AF, Calina D, Poulas K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33898273 15. COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment. SN Compr Clin Med 2021:1-7Hapshy V, Aziz D, Kahar P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3389892 Basic Science (93 articles) 1. Analysis of the Genomic Distance Between Bat Coronavirus RaTG13 and SARS-CoV-2 Reveals Multiple Origins of COVID-19. Acta Math Sci 2021; 41:1017-1022Pei S, Yau SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33897081 2. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule. Acta Pharmacol. Sin. 2021:1-18Lan XF, Olaleye OE, Lu JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33931765 3. Quantitative Evaluation of Aerosol Generation from Non-contact Tonometry and its Correlation with Tear Film Characteristics. Adv Ther 2021:1-11Hao W, Wu J, Zhao X et al.
Recommended publications
  • Exploring Mental Health & COVID-19: How a Pandemic Could Become
    Eastern Kentucky University Encompass Honors Theses Student Scholarship Spring 5-2021 Exploring Mental Health & COVID-19: How a Pandemic Could Become America's Next Mental Health Crisis Ashley D. Shofner Eastern Kentucky University, [email protected] Follow this and additional works at: https://encompass.eku.edu/honors_theses Recommended Citation Shofner, Ashley D., "Exploring Mental Health & COVID-19: How a Pandemic Could Become America's Next Mental Health Crisis" (2021). Honors Theses. 834. https://encompass.eku.edu/honors_theses/834 This Open Access Thesis is brought to you for free and open access by the Student Scholarship at Encompass. It has been accepted for inclusion in Honors Theses by an authorized administrator of Encompass. For more information, please contact [email protected]. EASTERN KENTUCKY UNIVERSITY Exploring Mental Health and COVID-19: How a Pandemic Could Become America’s Next Mental Health Crisis Honors Thesis Submitted in Partial Fulfillment of the Requirements of HON 420 Spring 2021 By Ashley D. Shofner Mentor Dr. Molly A. McKinney Associate Professor, Department of Health Promotion and Administration 3 An Abstract Of Exploring Mental Health and COVID-19: How a Pandemic Could Become America’s Next Mental Health Crisis By Ashley D. Shofner Mentor Dr. Molly A. McKinney Associate Professor, Department of Health Promotion and Administration Abstract Description: A pandemic can be described as an epidemic disease that has spread over a large geographical area and has become prevalent in numerous sectors of the globe. In 2020, just over 100 years since our last major pandemic, the 1918 Influenza outbreak, the global community is facing yet another threat: COVID-19.
    [Show full text]
  • Urgent SOS from Longcovid Sufferers
    Recognition · Research · Rehab www.longcovidsos.org [email protected] @LongCovidSOS 07 July 2020 Urgent SOS from LongCovid sufferers To: Rt Hon Boris Johnson MP, Prime Minister Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care Prof Chris Whitty, Chief Medical Officer for England, UK Government Chief Medical Adviser Dr Patrick Vallance, UK Government Chief Scientific Adviser Mr Simon Stevens, Chief Executive Officer NHS England John Connaghan CBE, Chief Executive NHS Scotland Mr Andrew Goodall, Chief Executive NHS Wales Mrs Valerie Watts, Chief Executive of The Health and Social Care Board for Northern Ireland Mr Duncan Selbie, Chief Executive Public Health England We are writing on behalf of thousands of forgotten victims of Covid-19 who have been sick since the early days of the outbreak. They are struggling to get help from the medical community for their continuing disease and feel abandoned by the government. The Covid-19 pandemic is estimated by the ONS to have infected around 7% of the UK population [1], [2] or approximately 4.6 million people; other studies suggest that the proportion infected could be as high as 25% [3]. In the early stages of the UK epidemic, government briefings and press reports were focussed on those who had severe symptoms and were at risk of being admitted to intensive care. People who had what were described as ‘mild’ symptoms were advised to stay in place and only present to hospital if their condition became critical. As a result, a significant number of sufferers battled with their symptoms at home, relying on advice from 111 which was not always helpful.
    [Show full text]
  • UK Set to Extend Coronavirus Lockdown 16 April 2020
    UK set to extend coronavirus lockdown 16 April 2020 rules not to go out except for exercise and to buy essential items. "I don't want to put all of that good effort to waste," said Hancock, who himself has also had coronavirus but recovered quickly. "Because if we just released all the measures then this virus would run rampant once again, and we can't let that happen." He did not say how long the lockdown would continue, but the law states that the measures must be reviewed every 21 days. Credit: CC0 Public Domain England's chief medical officer, Chris Whitty, said Wednesday that the outbreak was peaking but warned the numbers of deaths would keep rising. The British government was on Thursday expected Health ministry figures show 12,868 people in to extend a nationwide lockdown for another three hospital in Britain have so far died, making it one of weeks, amid signs the coronavirus outbreak is the worst affected countries in the global outbreak. peaking but also warnings of more deaths to come. Testing concerns Foreign Secretary Dominic Raab, who is standing The main opposition Labour party supports in for Prime Minister Boris Johnson as he extending the lockdown, but has called for the recuperates after spending a week in hospital with government to set out its exit strategy—a demand COVID-19, met with ministers and officials to ministers say is premature. finalise the plans. There are particular concerns about the slow An announcement is due later but the government expansion of testing for coronavirus, something has already said that, with the death toll many people believe is crucial to easing the approaching 13,000 and still rising, now is not the confinement measures.
    [Show full text]
  • The Reaction to the SARS-Cov-2 Virus Is the Most Reckless and Grossly Irresponsible 'Public Health' Response in History
    Elizabeth Hart <[email protected]> The reaction to the SARS-CoV-2 virus is the most reckless and grossly irresponsible 'public health' response in history Elizabeth Hart <[email protected]> Tue, Apr 6, 2021 at 9:42 PM Bcc: Elizabeth Hart <[email protected]> Please see below my email to Sir Patrick Vallance and Chris Whitty, UK Scientific and Medical Advisers, challenging them about the grossly disproportionate and ill-targeted response to SARS-CoV-2/Covid-19. This really is the most dire 'public health' response in history, and the bigger picture is very sinister. Elizabeth Hart Independent person investigating the over-use of vaccine products and conflicts of interest in vaccination policy ---------- Forwarded message --------- From: Elizabeth Hart <[email protected]> Date: Tue, Apr 6, 2021 at 3:34 PM Subject: The reaction to the SARS-CoV-2 virus is the most reckless and grossly irresponsible 'public health' response in history To: Patrick Vallance, Chris Whitty Cc: Fiona Godlee, Sharon Davies, Peter Doshi, Kamran Abbasi, Theodora Bloom, Allyson Pollock, John Ioannidis, Simon Wain-Hobson, Richard Ebright, Marc Lipsitch, Michael Osterholm, Tom Inglesby, Carl Heneghan, Michael Levitt, Martin Kulldorff, Jayanta Bhattacharya, Sucharit Bhakdi, Gus Dalgleish, Karol Sikora, Anders Tegnell, Johan Giesecke, Ian Frazer, Peter Doherty, Peter Collignon, Roy Anderson, Peter Openshaw, Adrian Smith, David Cannadine, Venki Ramakrishnan, Andrew Goddard, Chris Conlon, Dan Sumners, John Shine, Robert Clancy, Sunetra Gupta, Andrew Pollard, Heidi Larson, Graham Medley, Melinda Mills, John Bell, David Kennedy, Andrew Read, Neil Ferguson For the attention of: Sir Patrick Vallance, UK Government Chief Scientific Adviser Professor Chris Whitty, UK Chief Medical Adviser Sir Patrick Vallance and Professor Whitty The reaction to the SARS-CoV-2 virus is the most reckless and grossly irresponsible 'public health' response in history.
    [Show full text]
  • CEPI and COVID-19 VACCINES
    CEPI and COVID-19 VACCINES June 9, 2020 Nicole Lurie, MD, MSPH Strategic Advisor to the CEO and Incident Manager, COVID response team CEPI A world in which epidemics are no longer a threat to humanity CEPI accelerates development of vaccines against emerging infectious diseases and enables equitable access to these vaccines for affected populations during outbreaks 2 Image left slide (right-click to replace image) CEPI Strategic Objectives Preparedness Response Sustainability Advance access to safe and Accelerate the research, Create durable and equitable effective vaccines against development and use of solutions for outbreak emerging infectious diseases vaccines during outbreaks response capacity 3 3 Column slide Small images or graphics can be used to highlight key items. These should always be circular CEPI has multiple investments against its priority pathogens MERS Lassa Nipah Chikungunya Rift Valley fever Disease X 5 vaccine 6 vaccine 4 vaccine 2 vaccine 2 vaccine 3 platform candidates candidates candidates candidates candidates technologies 4 COVID-19 portfolio goals Speed Scale Access Developing Covid-19 vaccines at Scaling up and scaling out vaccine Working with global partners to pandemic speed manufacturing capacity ensure fair allocation of COVID-19 vaccines 5 CEPI vaccine development so far…. 23th May 31st Dec 2019 11th March 12th April 14th Feb First meeting of the ACT WHO notified of pneumonia-like case Wellcome Trust launch First cases reported in WHO declares Accelerator cluster in Wuhan, China COVID-Zero resource Africa
    [Show full text]
  • PROTESTS and REGIME SUPPRESSION in POST-REVOLUTIONARY IRAN Saeid Golkar
    THE WASHINGTON INSTITUTE FOR NEAR EAST POLICY n OCTOBER 2020 n PN85 PROTESTS AND REGIME SUPPRESSION IN POST-REVOLUTIONARY IRAN Saeid Golkar Green Movement members tangle with Basij and police forces, 2009. he nationwide protests that engulfed Iran in late 2019 were ostensibly a response to a 50 percent gasoline price hike enacted by the administration of President Hassan Rouhani.1 But in little time, complaints Textended to a broader critique of the leadership. Moreover, beyond the specific reasons for the protests, they appeared to reveal a deeper reality about Iran, both before and since the 1979 emergence of the Islamic Republic: its character as an inherently “revolutionary country” and a “movement society.”2 Since its formation, the Islamic Republic has seen multiple cycles of protest and revolt, ranging from ethnic movements in the early 1980s to urban riots in the early 1990s, student unrest spanning 1999–2003, the Green Movement response to the 2009 election, and upheaval in December 2017–January 2018. The last of these instances, like the current round, began with a focus on economic dissatisfaction and then spread to broader issues. All these movements were put down by the regime with characteristic brutality. © 2020 THE WASHINGTON INSTITUTE FOR NEAR EAST POLICY. ALL RIGHTS RESERVED. SAEID GOLKAR In tracking and comparing protest dynamics and market deregulation, currency devaluation, and the regime responses since 1979, this study reveals that cutting of subsidies. These policies, however, spurred unrest has become more significant in scale, as well massive inflation, greater inequality, and a spate of as more secularized and violent.
    [Show full text]
  • AMERICA in the FACE of the STORM أمريكا في وجه العاصفة !! العربي األمريكي اليوم Arab American Today
    مارس 2020 م - السنة الثامنة - العدد: March 2020 - Volume : 8 - Issue :87 87 ترامب يعاند الخبراء الصحيين ويتعامل بعقلية التاجر مع كورونا Survey reveals Yemen war’s ‘devastating impact’ on child mental health اليمن يستعد لمواجهة كورونا بنظام صحي هش World Bank could deploy $150 billion over 15 months in coronavirus battle زعماء مجموعة العشرين يتعهدون بجبهة موحدة ضد كورونا “Contigen” film predicted outbreaks of Corona virus 10 years ago دراسة »متفائلة« حول فيروس كورونا الجديد AMERICA IN THE FACE OF THE STORM أمريكا في وجه العاصفة !! العربي اﻷمريكي اليوم Arab American Today EVERY PERSON In Michigan Deserves Access To Good HEALTHCARE To fund life-saving programs like MIChild, urgent care, Medicaid and Medicare YOU and YOUR FAMILY must be counted in the 2020 CENSUS this spring. The 2020 CENSUS Is quick and EASY to fi ll out. Use it to count EVERYONE in your home. And by law, it is 100% CONFIDENTIAL For more information go to www.mivoicecounts.org 002 مارس 2020 م - السنة الثامنة - العدد: WWW.ARABAMERICANTODAY.NET 87 العربي اﻷمريكي اليوم Arab American Today مع تحيات مجلة العربي اﻷمريكي اليوم 003 March 2020 - Volume : 8 - Issue :87 WWW.ARABAMERICANTODAY.NET نصوص Provision العربي اﻷمريكي اليوم Arab American Today زهرة التوليب نصف سماء كئيبة عبد الجواد العوفير* وجه إيديت عمر الشيخ * الواقع. ُسقت ثروات تلك الشعوب، ِحوربت الشتاء يطرق الباب ثقافتهم، ثم جاء فنّان ّمدع ليستبيح حقّهم يف ٍ ٍبمعطف حزين تقرير مصري صغري، أ ّﻻ تُستغلَّ مﻻمحهم. قضيت عمرا ًبالنظر إىل حياتكم، دعوتها » للجلوس هنا، عىل كأس، فهل أفتح القلب ُسقت ثرواتهم ثم جاء فنّان ّمدع ليستبيح حقّهم رميت لها كل الحلوى ﻷجذب هوسها كي يدخل الحب؟ يف تقرير ٍمصري صغري بالجمال، لكن املرارات التي سنقولها » كانت أثقل من كحول العالم..
    [Show full text]
  • Can Communication Strategies Combat COVID-19 Vaccine
    Article Can Communication Strategies Combat COVID-19 Vaccine Hesitancy with Trade-Off between Public Service Messages and Public Skepticism? Experimental Evidence from Pakistan Qiang Jin 1, Syed Hassan Raza 2 , Muhammad Yousaf 3 , Umer Zaman 4,* and Jenny Marisa Lim Dao Siang 5 1 Intercultural Communication Research Center, Hebei University, Baoding 071000, China; [email protected] 2 Department of Communication Studies, Bahauddin Zakariya University, Multan 66000, Pakistan; [email protected] 3 Centre for Media and Communication Studies, University of Gujrat, Gujrat 50700, Pakistan; [email protected] 4 Endicott College of International Studies, Woosong University, Daejeon 34606, Korea 5 Department of Business Administration, School of Management, National Central University, Taoyuan City 32001, Taiwan; [email protected] * Correspondence: [email protected] Abstract: The COVID-19 pandemic may have reached a turning point as the World Health Organiza- tion and the global community of nations step up plans for mass vaccination campaigns. However, the COVID-19 vaccine-related conspiracy theories (e.g., falsehoods about birth control, women infer- tility, surveillance, and microchip humanity, etc.) have built new momentum for vaccine hesitancy. To this end, several nations worldwide, including Pakistan, are struggling to boost public trust Citation: Jin, Q.; Raza, S.H.; Yousaf, and enthusiasm to get vaccinated, especially in an anxious and complicated atmosphere propelled M.; Zaman, U.; Siang, J.M.L.D. Can by multiple, new
    [Show full text]
  • COVID-19 (Novel Coronavirus): What We Know, What We Don’T Know, and How We Can Plan Within Our Communities
    COVID-19 (novel coronavirus): What we know, what we don’t know, and how we can plan within our communities March 5, 2020 Andrew Lover, MS MPH PhD Dept. of Biostatistics and Epidemiology [email protected] School of Public Health and Health Sciences Updated Mar 7; v1.1. Overview 1. Some background 2. The virus and epidemiology 3. Response measures and community preparedness 4. Q & A School of Public Health and Health Sciences 2 Disclaimers All opinions in this talk are my personal views, and do not represent those of the Department of Biostatistics and Epidemiology; the School of Public Health and Health Sciences; or UMass-Amherst. Guidance is being rapidly updated; always consult your local, state and federal authorities for the most up-to-date information. (mass.gov and cdc.gov) General note: most/many current studies are preprints and are not yet peer reviewed; and data change hourly/daily. School of Public Health and Health Sciences 3 Terminology § Coronaviruses are a small class of human pathogens; four of which cause ‘normal’ respiratory infections. § Two others may cause severe infections: SARS-CoV, and MERS-CoV. MERS-CoV § Original name (Jan 2020): Wuhan flu or novel coronavirus-2019 § Current standard (allows for expansion) § Illness: COVID-19 (“coronavirus disease”) § Virus: SARS-CoV-2 § This structure parallels HIV/AIDS School of Public Health and Health Sciences 4 Population-level metrics § Endemic: The constant presence of a disease or infectious agent within a given geographic area or population group § Epidemic: The occurrence in a community or region of cases of an illness clearly in “excess of normal expectancy” (preferred) § Outbreak: An epidemic limited to localized increase in the incidence of a disease (avoid) § Pandemic: An epidemic occurring over a very wide area, crossing international boundaries and usually affecting a large number of people (national or global), but no specific criteria School of Public Health and Health Sciences 5 The first signal….
    [Show full text]
  • Do You Know of a Colleague And/Or Student Who Would Be Interested in Receiving These Bulletin Boards? Please Forward to Them
    Do you know of a colleague and/or student who would be interested in receiving these Bulletin Boards? Please forward to them. A quick email to [email protected] with the word “subscribe” in the subject line and the email address will be added to the listing. Geoscience Bulletin Board – 16 November 2020 – compiled by Elaine J. Hanford In Memoriam: Will Harrison (1936- 2020) – raffish glacial scientist • https://www.adn.com/alaska-news/science/2020/11/07/saying-goodbye-to-a-raffish-glacier- scientist/ Understanding Jökulhlaup - glacial lake floods • https://www.techexplorist.com/long-standing-mystery-glacial-lake-floods-solved/36039/ Distinct slab interfaces within mantle transition zone beneath western Pacific • https://www.eurekalert.org/pub_releases/2020-11/caos-dsi110920.php New model for predicting speed of earthquake propagation • https://www.eurekalert.org/pub_releases/2020-11/idrp-anm110920.php Dust in sediment cores from South Pacific reflect Ice Age climate history • https://www.eurekalert.org/pub_releases/2020-11/uoo-had110920.php Dotsero volcano in Colorado erupted roughly 4,200 years ago – phreatomagmatic eruption • https://coloradosun.com/2020/11/09/dotsero-volcano-colorado-active/ San Cristobal Verapaz deadly landslide triggered by heavy rains from Hurricane Eta in Guatemala • https://blogs.agu.org/landslideblog/2020/11/09/san-cristobal-verapaz/ Somalia heralding new oil & gas exploration • https://www.theafricareport.com/49364/somalia-the-new-oil-and-gas-frontier/ Drones measuring carbon dioxide emissions from Manam
    [Show full text]
  • COVID-19 Lockdown Exit Analysis 5Th Jun 2020
    COVID-19 Lockdown Exit Analysis 5th Jun 2020 News Highlights Encouraging signs as Spain reports zero deaths for second day running Spain, one of the countries worst affected by the coronavirus with 27,127 deaths, reported zero deaths for the second day in a row, amidst signs that the country has seen off the worst. At the peak of the pandemic, Spain saw hundreds of deaths every day from the virus. UK lockdown brings cleaner air and relief for asthma sufferers Millions of people suffering from respiratory conditions like asthma may have benefited from the cleaner air and clearer skies with the halting of industry and reduction of traffic due to the UK lockdown. According to the British Lung Foundation, a survey of 14,000 people with lung conditions revealed that one-in-four asthmatics felt relief in their symptoms with children seeming to benefit the most. AstraZeneca inks deal with partners to produce and distribute vaccine The drug company AstraZeneca stated it intends to partner with CEPI and Gavi to manufacture and distribute 300 million doses of an experimental Covid-19 vaccine created by Oxford University, if the vaccine is shown to be safe and effective. AstraZeneca also reached a licensing agreement with the Serum Institute of India, which has committed to providing 400 million vaccine doses to low and middle income countries by 2020 end. Exemptions for film crew sparks furore in New Zealand Director James Cameron and 55 crew members of the film 'Avatar 2' flew into New Zealand under a recently announced exemption based on economic value, while thousands who already have temporary visas are unable to enter.
    [Show full text]
  • Coronaconspiracy: Conspiracy Theories on Twitter and Youtube in the Age of Coronavirus Author: Sam Dodd // Institution: City, U
    #Coronaconspiracy: Conspiracy Theories on Twitter and YouTube in the Age of Coronavirus Author: Sam Dodd // Institution: City, University of London // Academic Year: 2019-2020 “When you have a situation where something defies explanation, people want better explanations than they’re getting, and that’s where conspiracy theories come from, that’s where they’ve always come from. People need to bring order to chaos” (VICE, 2020, 4:35). This essay will examine the most popular conspiracy theories circulated on Twitter and YouTube about the 2019-20 global pandemic COVID-19 (coronavirus), in the English language, for the one-week time frame 5th May 2020 – 11th May 2020, then examine news coverage originating from UK-based outlets related to those conspiracy theories for the two month period preceding this time frame, for background and context. It will ask what the roles of the law and regulators, the platforms themselves, and the information professional could be in this context. ~ Terminology The way that ‘most popular’ is measured is explained in ‘Twitter and YouTube Data Analysis: Research Parameters’ further on. The term ‘conspiracy theory’ is defined as: “the theory that an event or phenomenon occurs as a result of a conspiracy between interested parties; a belief that some covert but influential agency (typically political in motivation and oppressive in intent) is responsible for an unexplained event” (Oxford English Dictionary, 2020). This essay will explore what interested parties or influential agencies conspiracy theorists claim exist; and the motivation or intent that these agencies allegedly have. Background ‘COVID-19’, known also as ‘SARS-CoV-2’ and ‘Coronavirus Disease’, is a respiratory tract virus first identified in December 2019 in Hubei, a province of China.
    [Show full text]